Preboost

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Preboost
Generic name: BENZOCAINE
Manufacturer: The Female Health Company d/b/a Veru Healthcare
Product type: HUMAN OTC DRUG
SPL set ID: 155e4ba2-7f06-454e-ae7e-e55ef8f891e3
SPL ID: 036fa5d4-a566-486a-aa26-c9a3f01fbcfe
Version: 3
Effective date: 2017-04-07
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:47:22

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		part348	openfda.application_number
brand name		Preboost	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		The Female Health Company d/b/a Veru Healthcare	openfda.manufacturer_name
ndc	package	69681-432-10	openfda.package_ndc
ndc	product	69681-432	openfda.product_ndc
ndc11	package	69681043210	derived:openfda.package_ndc
spl id		036fa5d4-a566-486a-aa26-c9a3f01fbcfe	id
spl set id		155e4ba2-7f06-454e-ae7e-e55ef8f891e3	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor. Avoid contact with the eyes. If you or your partner develops a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor. Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.